Industry: Pharma & Healthcare
Published Date: 2025-01-01
Pages: 72 Pages
Report ld: 3445444
Request Sample
Customized Report
The global market for Myoview was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Myoview™ 30 mL (Kit for the Preparation of Technetium Tc-99m Tetrofosmin for Injection) is indicated for myocardial perfusion imaging under rest and/or exercise or pharmacologic stress conditions to delineate regions of reversible myocardial ischemia or infarcted myocardium in patients with known or suspected coronary artery disease.
North American market for Myoview is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Myoview is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Myoview include GE Healthcare, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Myoview, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Myoview.
The Myoview market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Myoview market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Myoview manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
GE Healthcare
Segment by Type
5 ml
30 ml
Segment by Application
Hospital
Clinic
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Myoview manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Myoview in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Myoview Market Overview
1.1 Product Definition
1.2 Myoview by Type
1.2.1 Global Myoview Market Value Comparison by Type (2024 VS 2031)
1.2.2 5 ml
1.2.3 30 ml
1.3 Myoview by Application
1.3.1 Global Myoview Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Myoview Market Size Estimates and Forecasts
1.4.1 Global Myoview Revenue 2020-2031
1.4.2 Global Myoview Sales 2020-2031
1.4.3 Global Myoview Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Myoview Market Competition by Manufacturers
2.1 Global Myoview Sales Market Share by Manufacturers (2020-2025)
2.2 Global Myoview Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Myoview Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Myoview, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Myoview, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Myoview, Product Type & Application
2.7 Global Key Manufacturers of Myoview, Date of Enter into This Industry
2.8 Global Myoview Market Competitive Situation and Trends
2.8.1 Global Myoview Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Myoview Players Market Share by Revenue
2.8.3 Global Myoview Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Myoview Market Scenario by Region
3.1 Global Myoview Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Myoview Sales by Region: 2020-2031
3.2.1 Global Myoview Sales by Region: 2020-2025
3.2.2 Global Myoview Sales by Region: 2026-2031
3.3 Global Myoview Revenue by Region: 2020-2031
3.3.1 Global Myoview Revenue by Region: 2020-2025
3.3.2 Global Myoview Revenue by Region: 2026-2031
3.4 North America Myoview Market Facts & Figures by Country
3.4.1 North America Myoview Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Myoview Sales by Country (2020-2031)
3.4.3 North America Myoview Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Myoview Market Facts & Figures by Country
3.5.1 Europe Myoview Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Myoview Sales by Country (2020-2031)
3.5.3 Europe Myoview Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Myoview Market Facts & Figures by Region
3.6.1 Asia Pacific Myoview Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Myoview Sales by Region (2020-2031)
3.6.3 Asia Pacific Myoview Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Myoview Market Facts & Figures by Country
3.7.1 Latin America Myoview Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Myoview Sales by Country (2020-2031)
3.7.3 Latin America Myoview Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Myoview Market Facts & Figures by Country
3.8.1 Middle East and Africa Myoview Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Myoview Sales by Country (2020-2031)
3.8.3 Middle East and Africa Myoview Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Myoview Sales by Type (2020-2031)
4.1.1 Global Myoview Sales by Type (2020-2025)
4.1.2 Global Myoview Sales by Type (2026-2031)
4.1.3 Global Myoview Sales Market Share by Type (2020-2031)
4.2 Global Myoview Revenue by Type (2020-2031)
4.2.1 Global Myoview Revenue by Type (2020-2025)
4.2.2 Global Myoview Revenue by Type (2026-2031)
4.2.3 Global Myoview Revenue Market Share by Type (2020-2031)
4.3 Global Myoview Price by Type (2020-2031)
5 Segment by Application
5.1 Global Myoview Sales by Application (2020-2031)
5.1.1 Global Myoview Sales by Application (2020-2025)
5.1.2 Global Myoview Sales by Application (2026-2031)
5.1.3 Global Myoview Sales Market Share by Application (2020-2031)
5.2 Global Myoview Revenue by Application (2020-2031)
5.2.1 Global Myoview Revenue by Application (2020-2025)
5.2.2 Global Myoview Revenue by Application (2026-2031)
5.2.3 Global Myoview Revenue Market Share by Application (2020-2031)
5.3 Global Myoview Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Company Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Myoview Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GE Healthcare Myoview Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Myoview Industry Chain Analysis
7.2 Myoview Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Myoview Production Mode & Process Analysis
7.4 Myoview Sales and Marketing
7.4.1 Myoview Sales Channels
7.4.2 Myoview Distributors
7.5 Myoview Customer Analysis
8 Myoview Market Dynamics
8.1 Myoview Industry Trends
8.2 Myoview Market Drivers
8.3 Myoview Market Challenges
8.4 Myoview Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
Myoview™ 30 mL (Kit for the Preparation of Technetium Tc-99m Tetrofosmin for Injection) is indicated for myocardial perfusion imaging under rest and/or exercise or pharmacologic stress conditions to delineate regions of reversible myocardial ischemia or infarcted myocardium in patients with known or suspected coronary artery disease.
Published Date: 2024-04-12
Pages: 70
USD 4900.00
(Single User License)
Myoview™ 30 mL (Kit for the Preparation of Technetium Tc-99m Tetrofosmin for Injection) is indicated for myocardial perfusion imaging under rest and/or exercise or pharmacologic stress conditions to delineate regions of reversible myocardial ischemia or infarcted myocardium in patients with known or suspected coronary artery disease.
Published Date: 2024-01-12
Pages: 68
USD 2900.00
(Single User License)
Myoview™ 30 mL (Kit for the Preparation of Technetium Tc-99m Tetrofosmin for Injection) is indicated for myocardial perfusion imaging under rest and/or exercise or pharmacologic stress conditions to delineate regions of reversible myocardial ischemia or infarcted myocardium in patients with known or suspected coronary artery disease.
Published Date: 2024-01-08
Pages: 86
USD 3950.00
(Single User License)
Myoview™ 30 mL (Kit for the Preparation of Technetium Tc-99m Tetrofosmin for Injection) is indicated for myocardial perfusion imaging under rest and/or exercise or pharmacologic stress conditions to delineate regions of reversible myocardial ischemia or infarcted myocardium in patients with known or suspected coronary artery disease.
Published: 2024-04-12
Pages: 70
Myoview™ 30 mL (Kit for the Preparation of Technetium Tc-99m Tetrofosmin for Injection) is indicated for myocardial perfusion imaging under rest and/or exercise or pharmacologic stress conditions to delineate regions of reversible myocardial ischemia or infarcted myocardium in patients with known or suspected coronary artery disease.
Published: 2024-01-12
Pages: 68
Myoview™ 30 mL (Kit for the Preparation of Technetium Tc-99m Tetrofosmin for Injection) is indicated for myocardial perfusion imaging under rest and/or exercise or pharmacologic stress conditions to delineate regions of reversible myocardial ischemia or infarcted myocardium in patients with known or suspected coronary artery disease.
Published: 2024-01-08
Pages: 86
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now